- $90.06m
- $68.57m
- $0.13m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.65 | ||
| Price to Tang. Book | 2.65 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 27.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -325.87% | ||
| Return on Equity | -1565.31% | ||
| Operating Margin | -6161.53% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.42 | 1.51 | 1.63 | 0.08 | 0.13 | 60.4 | 431.3 | -36.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Axe Compute Inc. is a virtual neocloud AI infrastructure platform. The Company provides customers with access to graphics processing unit (GPU) compute capacity for artificial intelligence (AI) and other high-performance computing workloads through a distributed network model, including infrastructure made available through the Aethir network. It also operates a digital asset treasury focused on the Aethir token (ATH), the native utility token of the Aethir network. Its segments include Compute Services and Treasury Management and Drug Discovery Services. Its Drug Discovery Services segment provides services that include the application of AI using its proprietary biobank of tumor samples, as well as creation of proprietary 3D culture models used in drug development. The Company provides enterprises and AI innovators with flexibility across hardware, geography, and deployment models through two offerings: Axe Compute Access and Axe Compute Build.
Directors
- J. Melville Engle CHM (72)
- Carl Schwartz PRE (79)
- Robert Myers CFO (66)
- Christina Jenkins DRC
- Raymond Vennare DRC
- Nancy Chung-Welch IND (61)
- Daniel Handley IND (61)
- Chuck Nuzum IND (73)
- Gregory St.Clair IND (55)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- December 11th, 2013
- Public Since
- December 18th, 2009
- No. of Shareholders
- 171
- No. of Employees
- 13
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 11,591,124
- Address
- 91 43RD STREET, SUITE 110, PITTSBURGH, 15201
- Web
- https://predictive-oncology.com/
- Phone
- +1 3026587581
- Auditors
- KPMG LLP
Latest News for AGPU
Upcoming Events for AGPU
Q3 2026 Axe Compute Inc Earnings Release
Axe Compute Inc Annual Shareholders Meeting
Q4 2026 Axe Compute Inc Earnings Release
Similar to AGPU
ABVC Biopharma
NASDAQ Capital Market
Acesis Holdings
NASDAQ Capital Market
Achieve Life Sciences
NASDAQ Capital Market
Aclarion
NASDAQ Capital Market
Acurx Pharmaceuticals
NASDAQ Capital Market
FAQ
As of Today at 19:28 UTC, shares in Axe Compute are trading at $7.77. This share price information is delayed by 15 minutes.
Shares in Axe Compute last closed at $7.77 and the price had moved by -8.37% over the past 365 days. In terms of relative price strength the Axe Compute share price has underperformed the S&P500 Index by -18.37% over the past year.
The overall consensus recommendation for Axe Compute is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAxe Compute does not currently pay a dividend.
Axe Compute does not currently pay a dividend.
Axe Compute does not currently pay a dividend.
To buy shares in Axe Compute you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $7.77, shares in Axe Compute had a market capitalisation of $90.06m.
Here are the trading details for Axe Compute:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: AGPU
Based on an overall assessment of its quality, value and momentum Axe Compute is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Axe Compute is $20.00. That is 157.4% above the last closing price of $7.77.
Analysts covering Axe Compute currently have a consensus Earnings Per Share (EPS) forecast of -$1.74 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Axe Compute. Over the past six months, its share price has outperformed the S&P500 Index by +10.11%.
As of the last closing price of $7.77, shares in Axe Compute were trading +18.15% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Axe Compute PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $7.77.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Axe Compute's management team is headed by:
- J. Melville Engle - CHM
- Carl Schwartz - PRE
- Robert Myers - CFO
- Christina Jenkins - DRC
- Raymond Vennare - DRC
- Nancy Chung-Welch - IND
- Daniel Handley - IND
- Chuck Nuzum - IND
- Gregory St.Clair - IND